A Trial of Rosuvastatin in Systemic Lupus Erythematosus

NCT01170585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Systemic Lupus Erythematosus

Interventions

DRUG: Rosuvastatin
DRUG: Placebo

Sponsor

Imperial College London